Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 56.31B | 51.24B | 47.52B | 42.31B | 40.59B | 39.07B |
| Cost of revenue | 10.22B | 9.21B | 8.49B | 7.57B | 7.38B | 7.31B |
| Research and development | 17.70B | 15.14B | 12.94B | 12.15B | 11.18B | 10.54B |
| Selling, general and administrative | 2.61B | 3.51B | 2.66B | 2.28B | 1.87B | 3.66B |
| Operating expenses | 33.44B | 30.71B | 27.08B | 24.76B | 23.24B | 24.22B |
| Operating income | 22.87B | 20.54B | 20.44B | 17.56B | 17.35B | 14.85B |
| Pre-tax income | 21.75B | 21.66B | 20.53B | 18.38B | 17.82B | 15.11B |
| Income tax | −5.02B | 18.95B | 2.20B | 1.74B | 2.13B | 1.64B |
| Net income | 26.77B | 2.71B | 18.34B | 16.64B | 15.69B | 13.47B |
| Earnings per share | 10.57 | 1.08 | 7.28 | 6.59 | 6.20 | 5.31 |
| Earnings per share, diluted | 10.44 | 1.05 | 7.14 | 6.43 | 6.03 | 5.16 |
| Weighted average shares | 2.53B | 2.52B | 2.52B | 2.53B | 2.53B | 2.53B |
| Weighted average shares, diluted | 2.56B | 2.57B | 2.57B | 2.59B | 2.60B | 2.61B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 23.43B | 35.87B | 10.19B | 12.01B | 28.75B | 43.89B | 43.85B | 32.05B |
| Short-term investments | 57.75B | 45.72B |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 32.23B | — | — | 24.03B | — | — |
| Depreciation and amortisation | 6.00B | — | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 34.26B |
| 35.07B |
| 41.48B |
| 33.93B |
| 27.05B |
| 26.04B |
| Receivables | 17.47B | 19.77B | 17.30B | 16.56B | 14.51B | 16.99B | 14.70B | 14.51B |
| Current assets | 109.77B | 108.72B | 73.12B | 73.61B | 90.23B | 100.05B | 91.07B | 76.43B |
| Goodwill | 24.75B | 24.53B | 21.16B | 20.65B | 20.65B | 20.65B | 20.65B | 20.65B |
| Total assets | 395.25B | 366.02B | 303.84B | 294.74B | 280.21B | 276.05B | 256.41B | 230.24B |
| Current liabilities | 46.75B | 41.84B | 36.96B | 37.31B | 33.89B | 33.60B | 33.33B | 27.00B |
| Long-term debt | 58.75B | 58.74B | 28.83B | 28.83B | 28.83B | 28.83B | 28.82B | 18.39B |
| Total liabilities | 151.57B | 148.78B | 109.78B | 99.67B | 95.18B | 93.42B | 91.88B | 73.48B |
| Equity | 243.68B | 217.24B | 194.07B | 195.07B | 185.03B | 182.64B | 164.53B | 156.76B |
| 3.90B |
| — |
| — |
| Share-based compensation | 6.03B | — | — | 4.15B | — | — |
| Capital expenditure | 19.00B | — | — | 12.94B | — | — |
| Investing cash flow | −33.68B | — | — | −20.01B | — | — |
| Dividends paid | 1.35B | 1.33B | 1.33B | 1.33B | 1.26B | 1.27B |
| Share buybacks | 0 | — | — | 12.75B | — | — |
| Financing cash flow | −6.55B | — | — | −19.50B | — | — |